Residual Ductal Carcinoma In Situ in Patients With Complete Eradication of Invasive Breast Cancer After Neoadjuvant Chemotherapy Does Not Adversely Affect Patient Outcome

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

1998 • 2,115 citations

Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy

1999 • 1,315 citations

The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27

2003 • 1,103 citations

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial

1999 • 1,034 citations

A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival

2003 • 850 citations

Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update

2006 • 711 citations

Gene Expression Profiles in Paraffin-Embedded Core Biopsy Tissue Predict Response to Chemotherapy in Women With Locally Advanced Breast Cancer

2005 • 617 citations

Incidence of and Treatment for Ductal Carcinoma In Situ of the Breast

1996 • 600 citations

Prognostic Value of Pathologic Complete Response After Primary Chemotherapy in Relation to Hormone Receptor Status and Other Factors

2006 • 578 citations

Gene Expression Profiles Predict Complete Pathologic Response to Neoadjuvant Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy in Breast Cancer

2004 • 545 citations

Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: A unicentre randomized trial with a 124-month median follow-up

1999 • 433 citations

Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome.

1995 • 422 citations

Weekly Paclitaxel Improves Pathologic Complete Remission in Operable Breast Cancer When Compared With Paclitaxel Once Every 3 Weeks

2005 • 406 citations

Outcome After Pathologic Complete Eradication of Cytologically Proven Breast Cancer Axillary Node Metastases Following Primary Chemotherapy

2005 • 399 citations

Incidence and Prognostic Significance of Complete Axillary Downstaging After Primary Chemotherapy in Breast Cancer Patients With T1 to T3 Tumors and Cytologically Proven Axillary Metastatic Lymph Nodes

2002 • 298 citations

Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer

2002 • 250 citations

Characteristics Associated With Recurrence Among Women With Ductal Carcinoma In Situ Treated by Lumpectomy

2003 • 237 citations

Nuclear structure in cancer tissues.

1957 • 222 citations

American Joint Committee on Cancer Tumor–Node–Metastasis Stage After Neoadjuvant Chemotherapy and Breast Cancer Outcome

2005 • 197 citations

Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma

2006 • 105 citations

High prognostic significance of residual disease after neoadjuvant chemotherapy: a retrospective study in 710 patients with operable breast cancer

2005 • 99 citations

Evidence-Based Use of Neoadjuvant Taxane in Operable and Inoperable Breast Cancer

2004 • 94 citations

p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast

1997 • 86 citations

The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: Preliminary results from national surgical adjuvant breast and bowel project protocol B-27

2004 • 69 citations

Primary Chemotherapy in the Treatment of Breast Cancer: The University of Texas M. D. Anderson Cancer Center Experience

2002 • 53 citations

Management of ductal carcinoma in situ

1995 • 21 citations

Physiologic and Pathologic Drug Resistance in Ovarian Carcinoma: A Hypothesis Based on a Clonal Progression Model

1998 • 19 citations

[Primary chemotherapy in the treatment of breast cancer].

1992 • 17 citations

Is It Really Duct Carcinoma In Situ?

2001 • 11 citations

Proliferating cell nuclear antigen in benign breast diseases.

1995 • 4 citations